Risorse esterne
Opinione della community
Prezzo Variazione Volume
0.5902 -1.68 €
P/E Obiettivo ad 1anno
0 1.75 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 30
Sell : 13

ELhattab Mostapha Profilo Prova Boaguze Machenesaccio LucaMazzu91 francesco Bartolomeo Vanzetti Simone Bonzanini Annie



Pain Therapeutics, Inc. (NASDAQ:PTIE) Files An 8-K Results of Operations and Financial Condition - Market Exclusive

Pain Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on drug development efforts on disorders of the nervous system, such as chronic pain. The Company's lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of ... Leggi

Trader's Buzzers: Pain Therapeutics Inc. (NASDAQ:PTIE), BlackBerry Limited (NASDAQ:BBRY) - TRA

Pain Therapeutics Inc. (NASDAQ:PTIE) ended its previous trading session at $0.6 with the Gain of 1.95%. The company's market cap is $27.26 Million, and the average volume is $373.8 Million. The 52-Week High range of the stock is $3, while the 52-week ...altro » Leggi

Stocks Alert: Simon Property Group Inc. (NYSE:SPG), Pain Therapeutics Inc. (NASDAQ:PTIE) - The Newburgh Press

The stock traded with the volume of 1.66 Million shares yesterday. The firm shows ... The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 1.75, with a high estimate of 1.75 and a low estimate of 1.75. The ...altro » Leggi

Average Rating Of Pain Therapeutics (NASDAQ:PTIE) At 5 - Markets Daily

Pain Therapeutics (NASDAQ:PTIE) has been given a 0.31 daily sentiment score. Additionally, Alpha One releases daily impact mark on 1 – 100 base. It entails about the chances of stock movement 1% minus or plus, in a certain trading session.altro » Leggi

Pain Therapeutics, Inc. (PTIE) held by 12 SEC 13F Filers - Post Analyst

Multiple company employees have indulged in significant insider trading. Pain Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director ROBERTSON SANFORD has acquired 50,000 shares of ... Leggi

Time To Put On The Watch List? – Pain Therapeutics, Inc. (NASDAQ:PTIE), Global Blood Therapeutics, Inc. (NASDAQ ... - The Voice Registrar

Pain Therapeutics, Inc. (NASDAQ:PTIE) rose to $0.6 per share in the last trading day compared to a prior close of $0.59. The management team hold 23.38 percent of the stock. Barbier Remi ranks as top insider in Pain Therapeutics, Inc., noted in the ... Leggi

Zacks: Pain Therapeutics (PTIE) Receives Consensus ... - Sports Perspectives

Shares of Pain Therapeutics (NASDAQ:PTIE) have earned an average broker rating score of 3.00 (Hold) from the one analysts that provide coverage for the ...altro » Leggi

Hot Biotech Stocks To Watch Right Now: Pain Therapeutics, Inc ... - The Independent Republic

Pain Therapeutics, Inc. (PTIE) ended last trading session with a change of 6.32 percent. It trades at an average volume of 346.60K shares versus 1.74M shares ... Leggi

Pain Therapeutics reports 4Q loss - Yahoo Finance

... Texas (AP) _ Pain Therapeutics (PTIE) on Friday reported a loss of $2.5 million in its fourth quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of 6 cents. The company's shares closed at 59 cents. A year ago, they ...altro » Leggi

Pain Therapeutics, Inc. (NASDAQ:PTIE) Approaching Earnings Date: What matter for investors? - The Voice Registrar

Pain Therapeutics, Inc. (NASDAQ:PTIE) is trading up 21.54% versus 12-month low of 0.51 and stands -79.33% lower from its 1-year peak of $3.00. The consensus price target (PT) of $1.75 means that the market expects Company shares to increase by ... Leggi